Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – In the first-line treatment of advanced colorectal cancer, the combination of cediranib and chemotherapy is comparable to bevacizumab plus chemotherapy in terms of…
Inhaled corticosteroids are the most widely used drugs for controlling asthma. Currently, U.S. guidelines recommend that adults with mild to moderate asthma should take this medication daily whether…
NEW YORK (Reuters Health) – The risk of developing lung cancer is significantly lower in people with excess body weight compared to those of normal weight, according to…
NEW YORK (Reuters Health) – Chemotherapy-induced delayed nausea remains a significant problem, despite the availability of second-generation antiemetics, researchers say. In a study they conducted, over half of…
NEW YORK (Reuters Health) – In advanced ovarian cancer, extensive lymph node dissection in a second-look operation does not improve survival, Italian researchers say. Their randomized trial addressed…
NEW YORK (Reuters Health) – Patients with esophageal cancer appear to have equally good survival after minimally invasive esophagectomy (MIE) or traditional open surgery, according to a new…
David Albert, MD, Founder & Chief Medical Officer, AliveCor, demonstrates the AliveCor ECG, an iPhone accessory that will allow both physicians and patients to capture and transmit clinical…
Time is crucial after an acute heart attack. Many patients undergo a primary percutaneous coronary intervention or PCI to open blocked coronary arteries. Cardiologists do this by implanting…
Ajay Verma, MD, PhD, VP, Neurodegeneration & Translational Neurology, Biogen Idec, talks about the importance of understanding programmed cell death in treating neurodegenerative disease. Filmed at FutureMed, in…
NEW YORK (Reuters Health) – In women with hormone-receptor-positive metastatic breast cancer, combining anastrozole and fulvestrant extends progression-free and overall survival, according to a paper released online today…
